Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.
about
Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy.High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: A phase III study by JALSG.Role of peripheral blood minimum residual disease at day 8 of induction therapy in high-risk pediatric patients with acute lymphocytic leukemia
P2860
Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Dose intensification of methot ...... the Children's Oncology Group.
@ast
Dose intensification of methot ...... the Children's Oncology Group.
@en
type
label
Dose intensification of methot ...... the Children's Oncology Group.
@ast
Dose intensification of methot ...... the Children's Oncology Group.
@en
prefLabel
Dose intensification of methot ...... the Children's Oncology Group.
@ast
Dose intensification of methot ...... the Children's Oncology Group.
@en
P2093
P2860
P1476
Dose intensification of methot ...... the Children's Oncology Group.
@en
P2093
Allen Chauvenet
Barbara L Asselin
Beverly A Bell
Bruce M Camitta
Edward C Halperin
Jeanette Pullen
Joanne Kurtzberg
Jonathan J Shuster
Meenakshi Devidas
Naomi Winick
P2860
P304
P356
10.1097/MPH.0000000000000131
P577
2014-07-01T00:00:00Z